A graduate of Miami University with a B.A. in Microbiology, Dr. Knoble received her M.D. from The Ohio State University Department of Medicine and Public Health. She completed her residency in internal medicine at The Ohio State University Medical Center, worked as an attending physician at Grant Medical System and served as faculty involved in the education of third-year Ohio State University medical students. She completed her fellowship in Hematology/Oncology at The University of Virginia Health System in Charlottesville and was an attending physician at Augusta Medical Center in Fisherville, VA. Dr. Knoble is a member of the American College of Physicians, American Society of Hematology, American Society of Clinical Oncology, Community Oncology Alliance, Columbus Medical Association, Ohio State Medical Association, and the Ohio/West Virginia Hematology Oncology Society.
Archive for the ‘Ohio Cancer Clinic’ Category
Jeanna L. Knoble, M.D.
Wednesday, July 7th, 2010
RADIATION ONCOLOGY
Tuesday, August 25th, 2009The Zangmeister Cancer Center offers world-class radiation oncology treatment options for a variety of cancers. Radiation therapy uses precisely controlled radiation to target cancer while sparing healthy tissue. Our advanced treatment options include Stereotactic Radiosurgery 
(SRS), where we treat brain tumors with sub-millimeter accuracy.
We also offer Stereotactic Body Radiation Therapy (SBRT), where we are able to treat some types of tumors with much fewer treatments. Utilizing advanced imaging techniques (4DCT) we are able to see how a tumor moves while the patient is breathing. Respiratory gating then allows us to deliver radiation to our patients only when tumor motion is minimal, greatly reducing risk of side effects to healthy tissue.
The Zangmeister Center also utilizes advanced technology (IGRT and IMRT) to ensure that we are targeting the tumor with precision during every treatment. Our team of radiation oncology physicians, physicists, dosimetrists, therapists and nurses work closely with patients, family members and their referring physicians to provide patient-focused care in a facility designed for easy access and comfort.
Cancer Patient Education
Tuesday, August 25th, 2009
We believe it’s important that our cancer patients have as much information and preparation as possible prior to chemotherapy treatment. As a result, every patient for whom their physician recommends chemotherapy is scheduled for a one-on-one consultation with one of our Nurse Practitioners. This 60-90 minute individualized education session reviews specific information about treatment drugs, side effects and symptom management. We strongly encourage patients to bring a family member or loved one to this session.
CHEMOTHERAPY / INFUSION
Tuesday, August 25th, 2009
Infusion is the administration of fluids, including chemotherapy and blood products, into the bloodstream of patients who require them.
More than half of all people diagnosed with cancer receive chemotherapy, treatments that use drugs to kill affected cells. For millions of people who have conditions that respond well to chemotherapy, this approach helps them to enjoy full, productive lives. Many side effects once associated with chemotherapy are now easily prevented or controlled, allowing many people to work, travel and participate in normal activities while receiving treatment.
Our infusion area features 90 comfortable infusion chairs situated in a naturally lit, open space. To pass the time, the center offers a variety of pleasant distractions – including Wi-Fi, reading materials and plenty of windows – all contributing to the warm, caring environment.
Clinical Trials
Tuesday, August 25th, 2009
Access to the most advanced treatments depends heavily on strong clinical trial programs. The Zangmeister Center is an active participant in a broad range of research studies in cooperation with pharmaceutical companies, The Gynecologic Oncology Group and The National Cancer Institute’s Cooperative Groups (including Southwest Oncology Group and the Eastern Cooperative Group), through the Columbus Community Clinical Oncology Program. Clinical trials give patients broader access to new treatment options and are essential to our mission of providing the most advanced care available to the patients we serve. In addition to providing promising alternatives to our patients today, these studies can dramatically improve the prognoses for generations of future oncology patients.
Cheryl Carr, M.S.N., C.N.P., C.N.S., A.O.C.N.
Monday, August 24th, 2009
Ms. Carr received her Bachelor of Science in Nursing from Ohio University and her Master of Science in nursing/adult nurse practitioner degree from Otterbein College. Prior to joining The Mark H. Zangmeister Center, she worked as an oncology nurse practitioner in Zanesville, Ohio. She serves as a facilitator of a Zanesville-area support group for the Central Ohio Leukemia/Lymphoma Society and is an “I Can Cope” program facilitator for the American Cancer Society. Ms. Carr is founding president of the SEO Oncology Nursing Society and a member of the National Oncology Nursing Society, from which she received the Roberta Scofield Memorial Certification Award. She is also a fellow of the Leadership Development Institute and a member of Outreach Ohio American Cancer Society (former president), Ohio Association of Advanced Practice Nurses, American College of Nurse Practitioners and the American Society of Clinical Oncology. Ms. Carr has been honored for her volunteer work by the Ohio House of Representatives.
Ming Zeng, M.D., Ph.D.
Monday, August 24th, 2009
 Dr. Zeng received his M.D. from The Military Medical College in Xian, China, and earned his Ph.D. in molecular biology and genetics from the University of Guelph, Canada. After serving his residency in therapeutic radiology at Yale-New Haven Hospital in New Haven, Connecticut, and in the Medicine Department at Penn Presbyterian Medical Center in Philadelphia, he completed his fellowship in the Radiation Oncology Department at the University of Pennsylvania School of Medicine. An attending physician in the Radiation Oncology Department at Mount Carmel Health System, Dr. Zeng is a member of the American Society for Therapeutic Radiology & Oncology and Columbus Community Clinical Oncology Program.
|
George Lewandowski, M.D., F.A. C.O.G
Monday, August 24th, 2009
A graduate of The Ohio State University College of Medicine, Dr. Lewandowski completed his residency in the Department of OB/GYN at Ohio State and his fellowship in gynecologic oncology at Georgetown University, where he served as an instructor in OB/GYN. He is a clinical assistant professor in the Department of OB/GYN at The Ohio State University College of Medicine and clinical associate professor at Wright State University School of Medicine, Obstetrics & Gynecology Department. Dr. Lewandowski is board certified in obstetrics & gynecology and gynecologic oncology by the American Board of Obstetrics and Gynecology and is a fellow of the American College of Obstetrics and Gynecology. He has re-certified annually since 2000. A participant in research activities as a member of the Gynecologic Oncology Group, he has served on the Mount Carmel Human Subject Protection Committee (Institutional Review Board) for more than 10 years. Dr. Lewandowski is a board member of the Mount Carmel Foundation, serving on the Development Subcommittee and Physician Philanthropy Committee. He is a member of the Society of Gynecologic Oncologists, Community Oncology Alliance and The Ohio State University Alumni Association (Life Member). He has twice been awarded the John G. Boutselis Award for Outstanding Teaching in the Department of Obstetrics & Gynecology at Mount Carmel Medical Center (awarded by The Ohio State University College of Medicine) and the OSU College of Medicine Faculty Teaching Award. He is institutional co-principal investigator for Mount Carmel Health: Gynecologic Oncology Group and is a peer review consultant for medical publications Gynecologic Oncology and Cancer.
P. Kothai Sundaram, M.D.
Monday, August 24th, 2009
Dr. Sundaram is board certified in medical oncology and internal medicine by the American Board of Internal Medicine. She received her M.D. from Coimbatore Medical College in India, where she completed a rotatory internship. Dr. Sundaram completed a clinical rotatory externship at East Carolina University in Greenville, North Carolina, where she also completed her residency and internship in internal medicine. Her clinical fellowship was completed in the Division of Hematology & Oncology at the Arthur G. James Cancer Hospital and Solove Research Institute, Department of Medicine, The Ohio State University, where she was awarded the Amgen Fellow. Dr. Sundaram is a member of the American Society of Hematology, American Society of Clinical Oncology, Community Oncology Alliance, Columbus Medical Association, The Ohio State Medical Association and the Ohio Hematology Oncology Society.
Jerry W. Mitchell, M.D.
Monday, August 24th, 2009
Dr. Mitchell received his undergraduate degree with honors in English from Wake Forest University and graduated from the University of North Carolina School of Medicine. He completed his residency at the University of Pittsburgh Department of Internal Medicine, where he received the Thomas O’Toole Award for care to the medically underserved community in Pittsburgh. He served as chief fellow at Wake Forest University in the Section on Hematology and Oncology. Dr. Mitchell is board certified in general internal medicine, hematology and medical oncology by the American Board of Internal Medicine. A member of the boards of The Mark H. Zangmeister Center and Concord Radiation Therapy, Dr. Mitchell also serves as chairman of the Grant Medical Center Cancer Committee. He is a member of the American Society of Clinical Oncology, American Society of Hematology, Community Oncology Alliance, Columbus Medical Association, The Ohio State Medical Association and the Ohio Hematology Oncology Society. Dr. Mitchell is a 2006 recipient of the “40 under 40” Award from Columbus Business First in recognition of his outstanding professional achievement and community service. Dr. Mitchell serves as Vice President of The Mark H. Zangmeister Center.
